GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

siltuximab   Click here for help

GtoPdb Ligand ID: 7396

Synonyms: cLLB8 | CNTO 328 | Sylvant®
Approved drug Immunopharmacology Ligand
siltuximab is an approved drug (EMA & FDA (2014))
Compound class: Antibody
Comment: Siltuximab is a monoclonal antibody targeting interleukin 6 (IL-6) [6].
Peptide sequences for the heavy and light chains of this antibody are annotated in its IMGT/mAb-DB record. The invention of siltuximab is claimed in patent US7291721 [2].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EU EMA (2014)  |  US FDA (2014)
International Nonproprietary Names Click here for help
INN number INN
9051 siltuximab
Synonyms Click here for help
cLLB8 | CNTO 328 | Sylvant®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 297
Other databases
GtoPdb PubChem SID 178103968
Immunopaedia Search siltuximab
PubChem SID 178103968
Search PubMed clinical trials siltuximab
Search PubMed titles siltuximab
Search PubMed titles/abstracts siltuximab
Wikipedia Siltuximab